Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Alchemia Ltd Announces Issue Of Shares

Sunday, 17 Mar 2013 08:57pm EDT 

Alchemia Limited announced the issuance of 34,000,000 fully paid ordinary shares to be issued as part of the institutional placement announced on March 11, 2013. The proceeds of the issue will be used by Alchemia Limited towards: Phase III trial and regulatory filings associated with HA-Irinotecan for mCRC; Manufacture of HA-Irinotecan for administration in mCRC; Corporate overheads, property and similar costs; HyACT research and development; Versatile assembly on stable templates technology research and development; and Phase II trial of HA-Irinotecan in small cell lung cancer. 

Company Quote

-0.0020 -2.35%
24 Nov 2014